Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-EN Version v11-EN
Language English English
Date Updated 2023-01-20 2021-12-22
Drug Identification Number 02150204 02150204
Brand name 0.9% SODIUM CHLORIDE INJECTION USP 0.9% SODIUM CHLORIDE INJECTION USP
Common or Proper name Sodium Chloride for Injection USP Sodium Chloride for Injection USP
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients SODIUM CHLORIDE SODIUM CHLORIDE
Strength(s) 9MG 9MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 10mL vial / fiole 10 x 10mL vial / fiole
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-02-01 2021-09-03
Estimated end date 2022-05-05 2022-02-07
Actual end date 2022-05-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product available. No longer on allocation.
Health Canada comments